Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Spartanburg, SC
NPI: 1013128792Primary Practice Location
SPARTANBURG MEDICAL CENTER
101 E Wood St, Spartanburg, SC
Primary Employer
Spartanburg Medical Center
spartanburgregional.com
HQ Phone
Get M.D. Vikas's Phone NumberMobile
Get M.D. Vikas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMS State Medical License
SC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 168 | 360 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 153 | 289 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 111 | 155 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 18 |
Hematuria--a rare presentation of Hodgkin lymphoma.
Authors: Stephanie Elkins
Journal: Clin Adv Hematol Oncol
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic.
Authors: Vivek Subbiah, Daniel Karp, Funda Meric, Sarina Piha-Paul, Neeta Somaiah
Publication Date: 2018-01-04
Cyclosporine dependent pure red cell aplasia: a case presentation.
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, OTHER: Fludeoxyglucose F-18, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, PROCEDURE: Computed Tomography, OTHER: Patient Observation, PROCEDURE: Echocardiography Test
Lead Sponsor: ImmunityBio, Inc.
Intervention / Treatment: DRUG: N-803 + Pembrolizumab, DRUG: N-803 + Nivolumab, DRUG: N-803 + Atezolizumab, DRUG: N-803 + Avelumab, DRUG: N-803 + Durvalumab, DRUG: N-803 + Pembrolizumab + PD-L1 t-haNK, DRUG: N-803 + Nivolumab + PD-L1 t-haNK, DRUG: N-803 + Atezolizumab + PD-L1 t-haNK, DRUG: N-803 + Avelumab + PD-L1 t-haNK, DRUG: N-803 + Durvalumab + PD-L1 t-haNK, DRUG: N-803 + Docetaxel + Pembrolizumab, DRUG: N-803 + Docetaxel + Nivolumab
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Capecitabine, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Leucovorin, OTHER: Patient Observation, DRUG: Leucovorin Calcium
